BeStock  

Amphastar Pharmaceuticals AMPH

$28.25 +$0.14 (+0.50%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $28.26 +0.04%
Open$28.14
Prev close$28.11
Day range$27.79 – $28.70
Volume498.5K
Market cap$1.20B
P/E (TTM)13.0
Dividend yield–

Fundamentals

Latest reported quarter: Q3, ended Sep 2026

Revenue$207.61M+8.2% YoY
Operating profit$50.77M+100.5% YoY
Net profit$37.76M+117.7% YoY
Diluted EPS$0.87+135.1% YoY
Free cash flow-$61.14M-229.4% YoY
Operating cash flow$43.30M

Revenue, last 8 quarters

$186.5MDec '24$170.5MMar '25$174.4MJun '25$191.8MSep '25$183.1MDec '25$171.2MMar '26$183.9MJun '26$207.6MSep '26

Net profit, last 8 quarters

$38.0MDec '24$25.3MMar '25$31.0MJun '25$17.4MSep '25$24.4MDec '25$6.4MMar '26$30.3MJun '26$37.8MSep '26

Diluted EPS by quarter

0.74Dec '240.51Mar '250.64Jun '250.37Sep '250.51Dec '250.14Mar '260.67Jun '260.87Sep '26

Free cash flow by quarter

$16.6MDec '24$24.4MMar '25$22.8MJun '25$47.2MSep '25$24.6MDec '25$38.3MMar '26$42.7MJun '26$-61.1MSep '26

Annual revenue

$349.8MFY20$437.8MFY21$499.0MFY22$644.4MFY23$732.0MFY24$719.9MFY25

Profitability & balance sheet

Gross margin46.8%
Operating margin18.7%
Net margin13.3%
Return on equity12.4%
Return on assets5.9%
Return on invested capital7.6%
Current ratio3.32
Liabilities / assets52.4%
Cash & investments$230.63M
Total debt$682.97M
Net cash (debt)-$452.34M
Free cash flow / sales6.0%

Where the revenue comes from

Quarter 2026/Q3

By business line

  • Other products$70.21M 33.8%
  • BAQSIMI$58.80M 28.3%
  • Primatene MIST$31.46M 15.2%
  • Lidocaine$16.64M 8.0%
  • Epinephrine$15.27M 7.4%
  • Glucagon$8.58M 4.1%
  • Ipratropium bromide$6.65M 3.2%

Income statement

Line item 2026 Q3 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4
Total Revenue as Reported $207.61M $183.90M $171.17M $719.89M $183.11M
Total Operating Revenue $207.61M $183.90M $171.17M $719.89M $183.11M
Cost of Revenue $107.98M $90.43M $100.85M $363.83M $97.44M
Gross Profit $99.63M $93.47M $70.32M $356.06M $85.67M
Operating Expense $48.86M $53.74M $56.69M $215.65M $50.06M
Selling and Admin Expenses $28.78M $31.58M $29.96M $129.81M $26.75M
-Selling & Marketing Expense $11.93M $13.34M $11.93M $43.89M $10.28M
-General & Admin Expense $16.84M $18.24M $18.03M $85.93M $16.47M
Research & Development $20.08M $22.16M $26.74M $85.84M $23.31M
Operating Profit $50.77M $39.73M $13.63M $140.40M $35.61M
Net Non-Operating Interest Income (Expense) -$4.47M -$4.37M -$4.15M -$16.80M -$4.21M
Non-Operating Interest Income $2.29M $2.29M $2.40M $8.68M $2.42M
Non-Operating Interest Expense $6.76M $6.66M $6.55M $25.48M $6.63M
Other Income (Expense) $2.76M $3.19M $575,000.00 $23,000.00 $515,000.00
Other Non-Operating Income (Expenses) $2.76M $3.19M $575,000.00 $23,000.00 $515,000.00
Pretax Profit $49.06M $38.54M $10.05M $123.62M $31.91M
Tax $11.30M $8.20M $3.63M $25.53M $7.49M
Net Profit $37.76M $30.35M $6.42M $98.09M $24.43M
Profit from Continuing Operations $37.76M $30.35M $6.42M $98.09M $24.43M
Net Income to Parent Company $37.76M $30.35M $6.42M $98.09M $24.43M
Net Income to Common Stockholders $37.76M $30.35M $6.42M $98.09M $24.43M
Basic EPS $0.89 $0.69 $0.14 $2.10 $0.53
Diluted EPS $0.87 $0.67 $0.14 $2.03 $0.51
– – – $0.00 –
Earnings from Equity Interest Net of Tax – – – – $0.00

Balance sheet

Line item 2026 Q3 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4
Total Assets $1.71B $1.74B $1.65B $1.63B $1.63B
Total Current Assets $602.69M $630.95M $633.68M $636.02M $636.02M
Cash and Cash Equivalents & Short-Term Investments $230.63M $290.12M $291.95M $282.81M $282.81M
-Cash and Cash Equivalents $204.59M $223.61M $170.94M $170.18M $170.18M
-Short Term Investments $26.05M $66.51M $121.01M $112.64M $112.64M
Receivables $184.75M $147.49M $157.45M $160.73M $160.73M
-Accounts Receivable $182.22M $144.86M $147.85M $143.56M $143.56M
-Taxes Receivable $2.53M $2.63M $9.61M $17.17M $17.17M
Inventory $173.92M $179.91M $170.19M $176.89M $176.89M
Restricted Cash $2.44M $2.44M $2.44M $2.44M $2.44M
Other Current Assets $10.95M $11.00M $11.65M $13.15M $13.15M
Total Non-Current Assets $1.11B $1.11B $1.01B $993.28M $993.28M
Net PPE $388.05M $389.13M $378.91M $353.72M $353.72M
-Gross PPE $717.24M $710.35M $692.28M $659.99M $659.99M
-Accumulated Depreciation -$329.20M -$321.22M -$313.37M -$306.27M -$306.27M
Goodwill and Other Intangible Assets $640.43M $647.83M $559.62M $565.97M $565.97M
-Goodwill $3.30M $3.31M $3.33M $3.40M $3.40M
-Other Intangible Assets $637.13M $644.52M $556.29M $562.56M $562.56M
Non-Current Deferred Assets $42.46M $42.46M $42.46M $42.46M $42.46M
Other Non-Current Assets $38.10M $33.39M $33.48M $31.14M $31.14M
Total Liabilities $897.17M $975.61M $874.77M $840.49M $840.49M
Total Current Liabilities $181.43M $263.21M $164.48M $158.16M $158.16M
Payables $36.62M $29.47M $35.91M $32.83M $32.83M
-Accounts Payable $34.48M $28.93M $35.50M $32.59M $32.59M
-Total Tax Payable $2.14M $546,000.00 $414,000.00 $239,000.00 $239,000.00
Current Accrued Expenses $133.59M $222.44M $117.19M $115.76M $115.76M
Short-Term Debt and Capital Lease Obligation $11.22M $11.29M $11.38M $9.57M $9.57M
-Current Debt $2.51M $2.49M $1.67M $1.64M $1.64M
-Current Capital Lease Obligation $8.72M $8.80M $9.71M $7.93M $7.93M
Total Non-Current Liabilities $715.74M $712.40M $710.29M $682.34M $682.34M
Long Term Debt and Capital Lease Obligation $680.47M $677.03M $675.00M $646.43M $646.43M
-Long Term Debt $610.50M $609.56M $609.80M $608.75M $608.75M
-Long Term Capital Lease Obligation $69.97M $67.47M $65.20M $37.68M $37.68M
Non-Current Deferred Liabilities $5.93M $5.93M $5.93M $5.93M $5.93M
Other Non-Current Liabilities $29.34M $29.44M $29.37M $29.98M $29.98M
Total Equity $814.55M $768.16M $773.39M $788.81M $788.81M
Stockholders' Equity $814.55M $768.16M $773.39M $788.81M $788.81M
Capital Stock $6,000.00 $6,000.00 $6,000.00 $6,000.00 $6,000.00
-Common Stock $6,000.00 $6,000.00 $6,000.00 $6,000.00 $6,000.00
-Preferred Stock $0.00 $0.00 $0.00 $0.00 $0.00
Additional Paid-In Capital $562.15M $553.00M $543.82M $535.38M $535.38M
Retained Earnings $741.41M $703.65M $673.30M $666.88M $666.88M
Less: Treasury Stock -$482.99M -$482.60M -$438.00M -$408.15M -$408.15M
Gains/Losses Not Affecting Retained Earnings -$6.02M -$5.90M -$5.74M -$5.31M -$5.31M
Investments and Advances – – – $0.00 $0.00

Cash flow

Line item 2026 Q3 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4
Operating Cash Flow $43.30M $51.32M $47.84M $156.12M $32.86M
Net cash flow from continuing operations $43.30M $51.32M $47.84M $156.12M $32.86M
Net Income from Continuing Operations $37.76M $30.35M $6.42M $98.09M $24.43M
Gain/Loss from Continuing Operations -$2.27M -$870,000.00 -$412,000.00 $2.53M $477,000.00
Depreciation & Depletion & Amortization $17.74M $16.46M $16.49M $63.20M $15.99M
Other Non-Cash Items $974,000.00 $875,000.00 $761,000.00 $3.36M $866,000.00
Change in Working Capital -$17.92M -$2.58M $15.31M -$65.97M -$42.73M
-Change in Receivables -$37.39M $2.98M -$4.55M -$6.37M $3.23M
-Change in Inventory $5.92M -$9.88M $6.25M -$21.06M $9.01M
-Change in Prepaid Assets -$2.11M -$2.54M -$2.33M -$3.53M $9.83M
-Change in Payables and Accrued Expense $15.86M $1.96M $9.60M -$4.56M -$42.64M
-Change in Other Current Liabilities -$1.89M -$2.20M -$1.42M -$5.61M -$1.66M
-Change In Other Working Capital $1.69M $7.11M $7.74M -$24.84M -$20.50M
Net cash flow from investing -$63.96M $44.87M -$16.73M -$70.33M -$60.57M
Net Cash Flow from Continuing Investing Activities -$63.96M $44.87M -$16.73M -$70.33M -$60.57M
Net PPE Purchase and Sale -$9.94M -$8.59M -$9.51M -$34.88M -$8.27M
Net Intangibles Purchase and Sale -$94.50M – – -$2.25M $0.00
Net Investment Purchase and Sale $40.82M $55.26M -$7.23M -$28.84M -$51.86M
Net Other Investing Changes -$338,000.00 – – -$4.36M -$434,000.00
Financing Cash Flow $1.71M -$43.54M -$30.21M -$67.43M -$18.37M
Net Cash Flow from Continuing Financing Activities $1.71M -$43.54M -$30.21M -$67.43M -$18.37M
Net Issuance Payments Of Debt -$33,000.00 -$525,000.00 -$29,000.00 $5.99M $169,000.00
Net Common Stock Issuance -$438,000.00 -$45.21M -$29.49M -$75.59M -$20.52M
Proceeds from Stock Option Exercised $2.18M $2.20M -$686,000.00 $2.86M $1.98M
Ending Cash Balance $204.82M $223.85M $171.17M $170.41M $170.41M
Net Change in Cash -$18.95M $52.66M $900,000.00 $18.36M -$46.08M
Beginning Cash Balance $223.85M $171.17M $170.41M $151.84M $216.50M
Effect of Exchange Rate Changes -$72,000.00 $16,000.00 -$138,000.00 $210,000.00 -$9,000.00
Free Cash Flow -$61.14M $42.73M $38.33M $118.98M $24.59M
Deferred Tax – – – $27.63M –
Net Business Purchase and Sale – – – $0.00 $0.00
Net Other Financing Charges – – – -$687,000.00 -$8,000.00

Discussion

No comments yet — be the first to weigh in on AMPH.

Sign in to join the discussion.

Scroll to Top